DENVER, Oct. 21 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (“Global Med” or the “Company”), has accepted an invitation to present at the 3rd Annual PIPEs Conference 2005 which is being held in New York City at The Waldorf-Astoria Hotel on October 26 and 27. Global Med will present at 9:00 a.m. and 2:00 p.m. on Wednesday, October 26, and also at 9:30 a.m. on Thursday, October 27.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO )
Global Med’s Chairman and CEO, Mick Ruxin, M.D., will provide a Company overview, along with an update on Global Med’s current operations and new developments, using both an audio and visual arrangement.
Conference officials estimate this year’s audience to be in excess of 1,000 attendees, consisting primarily of investors, investment bankers, attorneys, company executives and industry analysts active in the small cap equity market. The conference includes CLE-accredited workshops, roundtables and presentations from leading industry professionals. Information about the event can be found at www.thepipesconference.com.
About Global Med Technologies, Inc.
Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate’s products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate’s products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace(R) donor management system and the SafeTrace Tx(R)* advanced transfusion management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med’s products and services, please call 800-WYNDGATE or visit www.globalmedtech.com, www.peoplemed.com and www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release
*Patent Pending
Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.
CONTACT: Company, Michael I. Ruxin, M.D., of Global Med Technologies,Inc., +1-303-238-2000; or Investors, John Nesbett or Jordan Silverstein,both of The Investor Relations Group, +1-212-825-3210, for Global MedTechnologies, Inc.
